What is the recommended starting dose of sertraline for adults, elderly patients, and children/adolescents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Starting Dose for Sertraline

The starting dose of sertraline is 50 mg once daily for adults with major depressive disorder and obsessive-compulsive disorder, while panic disorder, PTSD, and social anxiety disorder should begin at 25 mg once daily for one week before increasing to 50 mg once daily. 1

Adult Dosing

For major depressive disorder and OCD, initiate sertraline at 50 mg once daily 1. This represents the optimal therapeutic dose when balancing efficacy and tolerability for most patients 2.

For panic disorder, PTSD, and social anxiety disorder, use a more cautious approach:

  • Start at 25 mg once daily
  • After one week, increase to 50 mg once daily 1

This lower initial dose for anxiety disorders helps minimize the initial anxiety or agitation that can occur as an adverse effect of SSRIs 3.

Dosing flexibility: Sertraline can be administered either in the morning or evening 1. The 50 mg starting dose is generally effective, though patients not responding may benefit from increases up to 200 mg/day, with dose changes made at intervals of at least one week given sertraline's 24-hour elimination half-life 1.

Elderly Patients

Elderly patients should also start at 50 mg once daily 1, 4. Unlike some other SSRIs, sertraline does not require altered dose recommendations in the elderly 2. An 8-week placebo-controlled trial in 747 elderly outpatients (≥60 years) used flexible dosing of 50-100 mg daily and demonstrated efficacy with good tolerability 4.

Pediatric/Adolescent Dosing

For children ages 6-12 with OCD: Start at 25 mg once daily 1

For adolescents ages 13-17 with OCD: Start at 50 mg once daily 1

After initiation, doses can be increased in 25-50 mg increments weekly as tolerated, up to a maximum of 200 mg/day 1. The lower body weight of children should be considered when advancing doses to avoid excess dosing 1. Pediatric pharmacokinetic studies show similar drug exposures to adults when adjusted for weight 5.

Important caveat: Sertraline is only FDA-approved for OCD in pediatric patients. It is not approved for depression in children and adolescents, as two placebo-controlled trials (n=373) in pediatric MDD did not provide sufficient data to support this indication 1.

Key Prescribing Considerations

  • Test dosing: Because initial adverse effects can include anxiety or agitation, consider starting with a subtherapeutic dose as a "test" dose, particularly in anxiety disorders 3
  • Titration schedule: Dose changes should occur at intervals of at least one week due to sertraline's 24-hour half-life 1
  • Monitoring: Close monitoring is essential during the first few months, especially for suicidality and unusual behavioral changes in all patients, but particularly in children and adolescents 6, 1
  • Discontinuation: All SSRIs, including sertraline, should be slowly tapered when discontinued due to risk of withdrawal effects 3, 6

The evidence consistently supports 50 mg daily as the optimal starting dose for most adult indications, with the notable exception of anxiety disorders where 25 mg for one week is preferred to minimize activation symptoms.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.